Ready to play
Ready to play
A recent Finnish study has revealed that the mineral lithium affects cells in Alzheimer's patients in more complex ways than previously thought, which may explain the variability in clinical trial results attempting to use it as a treatment. The findings showed that lithium's effects are not limited to the tau protein; it also alters other chemical sites and impacts a range of enzymes and proteins such as Rho GTPases, which play a role in organizing the structure and function of nerve cells. This provides a broader understanding of its potential mechanisms in the future.
Notice: This Is an AI-Generated Summary
Comments (0)